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RESEARCH ARTICLE
Host-specific differences in the response 
of cultured macrophages to Campylobacter 
jejuni capsule and O-methyl phosphoramidate 
mutants
Sungwon Kim1, Andrea Vela1, Sara M. Clohisey1, Spiridoula Athanasiadou2, Pete Kaiser1, Mark P. Stevens1 
and Lonneke Vervelde1*
Abstract 
Campylobacter jejuni is the leading cause of bacterial food-borne gastroenteritis worldwide and human infections 
are frequently associated with handling and consumption of contaminated poultry. The polysaccharide capsule 
of C. jejuni plays important roles in colonisation of the chicken gut, invasion of epithelial cells and serum resistance 
and is subject to modification with O-methyl phosphoramidate (MeOPN) in most strains. In this study, the cytokine 
responses of mouse bone marrow-derived macrophages (mBMMs), chicken bone marrow-derived macrophages 
(chBMMs) and human monocyte-derived macrophages (hMDMs) were measured following infection with C. jejuni 
11168H wild-type (WT) or isogenic mutants lacking either the capsule (Δcj1439) or its MeOPN modification (Δcj1417). 
Consistent with previous observations using murine bone marrow-derived dendritic cells, mutants lacking the cap-
sule or MeOPN elicited enhanced transcription of IL-6 and IL-10 in mBMMs compared to wild-type C. jejuni. However, 
the lack of capsule and MeOPN did not alter IL-6 and IL-10 expression in chBMMs and hMDMs compared to C. jejuni 
WT. Phagocytosis assays showed the acapsular mutant was not impaired in uptake or net intracellular survival after 
phagocytosis in both chicken and human macrophages; however, the phagocytosis of the MeOPN mutant was 
significantly decreased in both chicken and human macrophages. In conclusion, differences in the response of mac-
rophages of varying host origin to Campylobacter were detected. The absence of MeOPN modification on the capsule 
of C. jejuni did not alter the levels of innate cytokine expression in both chicken and human macrophages compared 
to the 11168H WT, but affected phagocytosis by host macrophages.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Campylobacter jejuni is the leading cause of bacterial 
food-borne gastroenteritis worldwide [1]. Approximately 
70 353 laboratory-confirmed cases of human infection 
were recorded by national surveillance in the United 
Kingdom from February 2014 to February 2015 (Zoon-
oses summary report UK 2014), however the true burden 
of infection in the community is expected to be far higher 
[2]. Symptoms of infection in humans vary from mild 
watery diarrhoea to severe bloody diarrhoea. Disease is 
usually self-limiting and symptoms last for 5–7 days, but 
in some cases the infection may be complicated by severe 
sequelae [3, 4]. Complications of infection include septi-
caemia and inflammatory neuropathies such as Guillain–
Barré syndrome that affect approximately 1/1000 cases 
[5, 6].
The human immune response to C. jejuni, includ-
ing the role of pattern recognition receptors and bacte-
rial agonists of innate and adaptive immunity, remains 
poorly understood. As in other enteric infections, 
innate immune cells are likely to be involved in the 
initial response to C. jejuni infection [7, 8]. Upon C. 
jejuni infection, human monocytic cell line THP-1 and 
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monocyte-derived dendritic cells (DCs) secrete a broad 
range of cytokines including IL-1β, IL-8, IL-10, IFN-γ, 
and TNF-α [9, 10]. Additionally, live C. jejuni induces a 
higher cytokine response in DCs than killed bacteria [11]. 
The pathogen recognition receptors, toll-like receptors 
(TLR) 2 and 4 have been shown to be involved in sig-
nalling and cytokine expression upon infection with C. 
jejuni in  vitro using knock-out or knock-down technol-
ogy [12, 13]. A luciferase-based TLR reporter assay, how-
ever, indicated that live C. jejuni did not directly activate 
human TLR2, TLR4, and TLR5 [14]. Human monocytes/
macrophages also efficiently kill C. jejuni [15].
Chickens are the key reservoir of human Campylobac-
ter infection and up to 50–70% of human cases have been 
attributed to the handling and consumption of contami-
nated broiler meat [3, 4]. Campylobacter colonization of 
chickens is widespread and results in long-term persis-
tence and shedding [16, 17]. Although large numbers of 
bacteria are in close contact with the epithelial cell layer, 
primarily in the large blind caeca (where C. jejuni number 
may exceed  109 CFU/g), no haemorrhagic lesions, caecal 
dilation and clinical signs of intestines are seen in most 
colonised birds [18] in clear contrast to humans who 
develop severe clinical symptoms of diarrhoea. In terms 
of immune responses, several reports have shown induc-
tion of immune-associated gene expression after Campy-
lobacter colonization of chickens. Indeed, evidence exists 
that C. jejuni can elicit gut pathology, pro-inflammatory 
responses and impair weight gain in some, but not all, 
commercial broiler lines [19]. Experimental infection 
of a commercial broiler line A1 elicits expression of the 
pro-inflammatory chemokines CXCLi1, CXCLi2 and 
IL-1β in the ceca at 2 and 5 days post-infection. Moreo-
ver, the infected A1 birds developed diarrhoea at 12 days 
post-infection [19]. Another study reported that experi-
mental infection of a commercial broiler line (Ross 308) 
with C. jejuni leads to increased mRNA levels of TLR4 
and TLR21 in peripheral blood leukocytes, but decreased 
transcription of other antimicrobial peptide genes in 
response to C. jejuni infection [20]. Additionally, C. jejuni 
infection increases the expression of pro-inflammatory 
cytokines (IL-1β and IL-6) and chemokines (CXCLi1 and 
CXCLi2) both in vitro as well as in vivo in ileum and cae-
cum [21–23]. Infection of C. jejuni leads to an increased 
number of circulating monocytes/macrophages in com-
mercial broiler chickens (Ross 308) [20], and an increased 
number of heterophils are recruited in the ileum and 
caeca of specific pathogen-free chickens challenged with 
C. jejuni [23]. Similar to human, chicken peritoneal mac-
rophages are able to ingest and kill C. jejuni effectively in 
the in vitro assay [24].
The analysis of the genome sequence of C. jejuni 
NCTC 11168 revealed that approximately 8% of its 
predicted coding sequences are devoted to the biosyn-
thesis of sugar moieties and bacterial surface glycans 
including lipo-oligosaccharide (LOS), capsular poly-
saccharide (CPS) and N- and O-linked glycosylation 
systems [25]. The CPS plays important roles for both 
serum resistance and invasion of epithelial cells [26]. 
The CPS produced by C. jejuni strains is structurally 
complex and highly variable, due in part to the addi-
tion of phase-variable modifications such as O-methyl, 
ethanolamine, aminoglycerol and O-methyl phospho-
ramidate (MeOPN) groups [27–29]. Earlier studies 
reported that approximately 70% of C. jejuni isolates 
have MeOPN modification, which has important roles 
in invasion of epithelial cells and serum resistance [26, 
30]. The loss of MeOPN modification leads to increased 
invasion of epithelial cells compared to the wild-type 
(WT) strain but with no effect on adherence [30]. A 
capsule-deficient mutant (Δcj1439) showed significantly 
decreased adherence and invasion to epithelial cells 
compared to C. jejuni WT [30, 31]. While the capsule 
plays a key role in colonisation of the chicken gut [32], 
the absence of MeOPN modification reportedly does 
not affect colonisation of C. jejuni in the chicken [20], 
albeit modest attenuation of a MeOPN mutant was 
observed in piglets [30]. In mouse bone marrow-derived 
dendritic cells (mBMDCs), both capsule (Δcj1439) and 
MeOPN (Δcj1417) mutants significantly enhances IL-6 
and IL-10 mRNA and protein expression compared to 
WT of C. jejuni [33].
In this study, the effect of the capsule and its MeOPN 
modification on the cytokine responses of macrophages 
from mice, chickens and human to C. jejuni was exam-
ined. Both capsule (Δcj1439) and MeOPN (Δcj1417) 
mutant strains did not alter cytokine responses in 
chicken and human macrophages, whereas enhanced 
cytokine responses were observed in mBMMs by the 
capsule and MeOPN deficient mutants. Furthermore, the 
lack of MeOPN modification reduced bacterial uptake, 
but not net intracellular survival, in chicken and human 
macrophages compared to C. jejuni WT.
Materials and methods
Animals
Commercial Novogen brown layers and C57/B16 mice 
were housed in premises licensed under a UK Home 
Office Establishment License in full compliance with the 
Animals (Scientific Procedures) Act 1986 and the Code 
of Practice for Housing and Care of Animals Bred, Sup-
plied or Used for Scientific Purposes. Requests for ani-
mals were approved by the local Animal Welfare and 
Ethical Review Board and animals were humanely culled 
in accordance with Schedule 1 of the Animals (Scientific 
Procedures) Act 1986.
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Isolation and culture of mouse bone marrow‑derived 
macrophages (mBMMs)
Vials of frozen C57BL/6 mouse bone marrow were 
kindly provided by Dr Hu (The Roslin Institute), follow-
ing recovery by standard methods. The mBMMs were 
differentiated following the protocol of Irvine et al. [34] 
in the presence of rhCSF1. Briefly, the bone marrows 
were cultured on 90-mm plastic petri dishes with RPMI 
1640 (Sigma) supplemented with 10% (v/v) FBS (Gibco), 
2  mM  l-glutamine, 100 U/mL Penicillin, 100  µg/mL 
Streptomycin (Gibco) and recombinant human colony-
stimulating factor-1 (rhCSF1, a gift from Chiron, Emer-
yville, CA, USA, 1  ×  104  U/mL as final concentration) 
for 7  days for differentiation into macrophages [34]. At 
day 4 post-seeding, 10  mL of fresh culture media with 
 104  U/mL rhCSF1 was added per petri dish. At 7  days 
post-seeding, the differentiated mBMMs were harvested 
using 10 mM EDTA, and re-plated at a concentration of 
1  ×  106 cells/well in 6-well plates for inoculation with 
bacterial strains or agonists and analysis of gene expres-
sion. The cells were cultured for 24 h in a humidified 5% 
 CO2 atmosphere prior to stimulation.
Isolation and culture of chicken bone marrow‑derived 
macrophages (chBMMs)
Chicken macrophages were differentiated from bone 
marrow isolated from embryos at day 20 of development. 
Bone marrow was harvested by flushing femurs and tib-
ias, and washed once with chilled RPMI 1640 medium. 
Approximately 1.0  ×  107 bone marrow cells were cul-
tured on 90-mm plastic petri dishes as previously 
described [35] in RPMI 1640 medium supplemented 
with 10% (v/v) FBS, 10 U/mL Penicillin, 10 μg/mL Strep-
tomycin, 2  mM  l-glutamine and 350  ng/mL recombi-
nant chicken CSF1 (rchCSF1) at 41  °C in a humidified 
5%  CO2 atmosphere for 7  days to allow macrophage 
differentiation. The media was changed on 2 and 4 days 
post-seeding. At 7  days post-seeding, the differentiated 
macrophages were harvested using 30  mM EDTA, and 
re-plated at a concentration of 2 × 106 cells/well in 6-well 
plates and 5  ×  105 cells/well in 24-well plates for gene 
expression studies and phagocytosis assays, respectively. 
The cells were cultured for 24 h prior to stimulation.
Isolation and culture of human  CD14+ monocyte‑derived 
macrophages (huMDMs)
Human  CD14+ mononuclear cells were isolated from 
blood of consenting donors under ethical approval from 
Lothian Research Ethics Committee (11/AL/0168). 
Briefly, the buffy coat was isolated from whole blood by 
centrifugation, followed by isolation of mononuclear 
cells by gradient separation using Lymphoprep (Stem-
cell Technologies). The isolated mononuclear cells were 
washed, and  CD14+ monocytes were positively selected 
and purified using MACS with CD14 microbeads (10 µL 
per  107 cells; Miltenyl Biotec). The purified  CD14+ 
monocytes were directly seeded and differentiated on 
either 6-well plates with 1  ×  106 cells/well for gene 
expression studies or 24-well plates with 5 ×  105 cells/
well for phagocytosis study, and cultured with RPMI 1640 
(Sigma) supplemented with 10% (v/v) FBS (GE Health-
care), 2  mM  l-glutamine, 100  U/mL penicillin, 100  µg/
mL streptomycin (Sigma), and rhCSF1 (1 × 104 U/mL as 
final concentration) [34] for 7 days for differentiation into 
macrophages and achieved a comparable density at the 
time of inoculation to the avian and murine macrophage 
cultures. Infections were performed on day 8.
Bacterial strains, culture and determination of bacteria 
concentration
Bacterial strains used in this study are C. jejuni 11168H 
(WT), an isogenic Δcj1417 mutant lacking phosphorami-
date side branch (MeOPN) [36], and acapsular Δcj1439 
mutant [37] (kindly provided by Prof. Brendan Wren, 
London School of Hygiene & Tropical Medicine). All 
bacteria were cultured under microaerophilic conditions 
(5%  O2, 5%  CO2, and 90%  N2) at 41 °C as described pre-
viously [38]. Initially, cultures were grown on modified 
charcoal-cephoperazone-deoxycholate agar (mCCDA; 
Oxoid) plates for 48 h, supplemented with selective sup-
plement containing with cefoperazone (32  mg/L) and 
amphotericin B (10  mg/L; Oxoid), in the presence of 
kanamycin (50 µg/mL as final concentration) for mutant 
strains. A single colony from the initial culture was 
selected and inoculated to 10  mL of Mueller–Hinton 
broth (Oxoid), followed by additional culture for 24 h at 
41  °C with 400  rpm shaking. Twenty-four hours post-
inoculation, morphology and motility of the bacteria was 
observed using KOVA  Glasstic® slide with grid (Kova), 
with only spiral-shaped and rapidly motile cultures being 
used. Absorbance was measured at 600 nm wavelength. 
For live bacteria, the cultured bacteria were collected by 
centrifugation at 13 000 × g for 10 min. The bacterial pel-
lets were washed with sterile PBS once, and then resus-
pended with PBS. The number of live bacteria used for 
stimulation was subsequently verified by serial dilution 
and plating to establish viable bacterial cell count.
To fix the bacteria, the cultured bacteria were pel-
leted by centrifugation at 13 000  ×  g for 10  min. The 
bacteria were resuspended in 200 μL of sterile PBS, and 
mixed with an equal volume of 4% (w/v) paraformalde-
hyde in PBS for 1  h at room temperature. The bacteria 
were washed 3 times with PBS prior to incubation with 
macrophages. Bacterial fixation was confirmed by micro-
scopic observation and plating to establish elimination of 
viability.
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Stimulation of macrophages with C. jejuni
The chBMMs and mBMMs were harvested and re-
plated in 6-well plates  24  h prior to stimulation. The 
live and fixed bacteria were diluted with RPMI 1640 
medium supplemented with 10% (v/v) FBS, 2 mM l-glu-
tamine and either rchCSF1 or rhCSF1, and were added 
to the prepared cells at MOIs of 50 or 100 for 3 or 6  h 
for subsequent analysis. For huMDMs, diluted bacteria 
were added directly into the huMDMs differentiated for 
8  days. Lipopolysaccharide from Salmonella minnesota 
R595 (100 ng/mL as final concentration; InvivoGen) [39] 
was used as a positive control and PBS in the culture 
media as negative control.
Quantitative real‑time PCR (qRT‑PCR)
Total RNA was extracted from the stimulated mac-
rophages using the RNeasy Mini Spin Column (Qia-
gen) and 1 μg of total RNA was reverse transcribed with 
cDNA synthesis kit (Bio-Rad), followed by 1:5 dilution 
for target transcripts and 1:100 dilution for 28S riboso-
mal RNA. To measure mRNA level from the chBMMs, 
2 μL of diluted cDNA was used with  TaqMan® Fast Uni-
versal PCR Master Mix (Applied Biosystems, UK) and 
TaqMan primer and probes (Table  1). For the mRNA 
levels of human or mouse macrophages, 2 μL of diluted 
cDNA was mixed with Fast  SYBR® Green Master Mix 
(Applied Biosystems) and specific primer sets (Table 1). 
All qRT-PCR was performed by Applied Biosystems 7500 
Fast real-time PCR system. Cycle thresholds were nor-
malised to internal control (28 s for chicken and human 
and β-actin for mouse) and calibrated to a medium-
treated control sample for relative quantification using 
the ΔΔCt method [40]. The results were presented as a 
fold change.
Phagocytosis assay
The assay was performed as described previously [41], 
with slight modifications. Twenty-four hours prior to 
stimulation, 5 ×  105 cells/well of chBMMs were seeded 
into 24-well plates. For huMDMs, the purified  CD14+ 
monocytes were seeded on 24-well plates at a density of 
5 × 105 cells/well. The prepared cells were inoculated at 
an MOI of 50 for 30 min without antibiotics. Then, the 
cells were washed three times with PBS, followed by 
treatment with gentamicin (200  µg/mL as a final con-
centration) for 30  min to kill extracellular bacteria. The 
cells were washed three times with PBS, incubated for 0 
or 3 h with RPMI 1640 supplemented with 10% (v/v) FBS, 
20 µg/mL of gentamicin and either rchCSF1 or rhCSF1, 
and subsequently lysed with 0.5% Triton X-100 on ice. 
The collected lysates were prepared by tenfold serial dilu-
tion with PBS and plated on mCCDA plates to deter-
mine intracellular bacteria. The colonies were counted, 
followed by the calculation of the CFU/mL and the per-
centage of killed bacteria to measure net intracellular 
survival.
Statistical analysis
All data were analysed by Student’s t test or one-way 
analysis of variance (ANOVA) using program R [42], and 
significant differences between groups were considered 
significant by Tukey’s honest significant difference (HSD) 
test at P < 0.05 (confidence level = 95%).
Results
Capsule and MeOPN mutants of C. jejuni elicit enhanced 
cytokine responses in mBMMs
Rose et al. [33] previously described the induction of dif-
ferential responses in murine dendritic cells using the 
Table 1 Primer sequences for qRT-PCR analyses of cytokine transcripts
Gene Forward primer Probe Reverse primer Accession no.
Chicken
 28S GGCGAAGCCAGAGGAAACT AGGACCGCTACGGACCTCCACCA GACGACCGATTTGCACGTC AH001604
 IL-1β GCTCTACATGTCGTGTGTGATGAG CCACACTGCAGCTGGAGGAAGCC TGTCGATGTCCCGCATGA NM_204524
 IL-6 GCTCGCCGGCTTCGA AGGAGAAATGCCTGACGAAGCTCTCCA GGTAGGTCTGAAAGGCGAACAG NM_204628
 CXCLi1 TGGCTCTTCTCCTGATCTCAATG TCGCTGAACGTGCTTGAGCCATACCTT GCACTGGCATCGGAGTTCA Y14971
IL-10 CATGCTGCTGGGCCTGAA CGACGATTCGGCGCTGTCACC CGTCTCCTTGATCTGCTTGATG NM_001004414
Human
 28S GAATTCATGGACGACACGAG ACTGTGACAGACCATTCCCA NR_003279
 IL-6 CCAGAGCTGTGCAGATGAGT CTGCGCAGAATGAGATGAGT NM_000600
 IL-10 GAGGCTACGGCGCTGTCAT TGCTCCACGGCCTTGCT NM_000572
Mouse
 β-actin TCCAGCCTTCCTTCTTGGGT GCACTGTGTTGGCATAGAGGT NM_007393
 IL-6 GGGACTGATGCTGGTGACAACC GGAGAGCATTGGAAATTGGG NM_031168
 IL-10 CGATGACGGGCCAGTGAGAATG TCAACACGTGGGCAGGATAGGCT NM_010548
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same strains of C. jejuni. To ensure that the bacteria used 
in our study would give similar responses, we repeated 
the study of Rose and stimulated mBMDCs at a multiplic-
ity of infection (MOI) of 50 with live or fixed wild-type 
(WT) C. jejuni 11168H or isogenic capsule (Δcj1439) 
and MeOPN (Δcj1417) mutants for 3  h. We confirmed 
that mBMDCs expressed significantly enhanced IL-6 and 
IL-10 mRNA levels after stimulation with the capsule and 
MeOPN deficient mutants of C. jejuni (see Additional 
file 1).
After confirming that the bacteria induced similar 
responses to previously published data [33], we then 
stimulated mBMMs with the same strains of C. jejuni 
under the same condition to examine the effect of cap-
sular and its modification on macrophage responses. 
mBMMs expressed significantly higher mRNA lev-
els of IL-6 and IL-10 after stimulation with the capsule 
and MeOPN deficient mutants of C. jejuni compared 
to the C. jejuni WT (Figure  1). The expression levels of 
the cytokines did not differ after stimulation with live or 
fixed C. jejuni.
Cytokine responses of chBMMs and huMDMs to C. jejuni 
are not affected by the capsule of MeOPN modification
To examine the role of the capsule and its MeOPN 
modification on the innate immune response of chicken 
macrophages to C. jejuni, live or fixed C. jejuni WT 
and capsule (Δcj1439) and MeOPN (Δcj1417) mutants 
were incubated with chBMMs for 3 and 6 h at an MOI 
of 50, and transcripts of inflammation-related signature 
cytokines were measured (Figure  2). The C. jejuni WT, 
capsule (Δcj1439) and MeOPN (Δcj1417) mutants all 
significantly induced transcription of the pro-inflamma-
tory cytokines IL-1β and IL-6, the chemokine CXCLi1, 
and anti-inflammatory cytokine IL-10, compared to the 
negative control incubated with PBS (Figure 2). A simi-
lar induction of responses was observed with live or fixed 
bacterial cells (Figure 2). However, in contrast to obser-
vations with murine cells, no statistically significant dif-
ferences in the mRNA levels of IL-1β, IL-6, CXCLi1 and 
IL-10 were detected after stimulation with the WT or 
mutant strains of C. jejuni. Increasing the MOI to 100 did 
not result in significantly different transcript levels for 
the cytokines, either across the strains or time intervals 
measured (see Additional file 2).
Since TLR4 can trigger inflammatory cytokine 
response in mammalian innate immune cells by bind-
ing to LOS of C. jejuni [10, 43], changes in chicken TLR4 
transcript levels upon the stimulation with WT and 
mutant C. jejuni strains were investigated (see Addi-
tional file  3). Stimulation of chBMMs with Salmonella 
LPS for 3  h led to the downregulation of TLR4 mRNA 
compared to the cells incubated with medium, as previ-
ously reported [44, 45]. Expression of TLR4 mRNA was 
significantly decreased following stimulation with all 
three strains of C. jejuni; however there was no difference 
of chicken TLR4 transcript levels observed among WT, 
capsule (Δcj1439) and MeOPN (Δcj1417) mutants of C. 
jejuni regardless of whether live or fixed bacterial cells 
were used (see Additional file 3).
Since C. jejuni is a zoonotic bacterium with relatively 
contrasting symptoms in chicken and human, human 
 CD14+ MDMs were cultured and stimulated with an 
MOI 50 of live or fixed WT or mutant C. jejuni for 3 h 
Figure 1 Campylobacter jejuni capsule and MeOPN mutants elicit an enhanced cytokine responses in mBMMs. Live or fixed C. jejuni 
11168H (WT), Δcj1417 (MeOPN) and Δcj1439 (capsule) mutants were incubated with mBMMs at MOI 50 for 3 h. Salmonella LPS was used as a 
positive control, while PBS in the medium was used as a negative control. Graphs show representative results of two independent experiments 
and error bars are the standard deviation of two independent experiments. Asterisks indicate a statistically significant difference of mRNA levels of 
inflammatory-related cytokines compared to C. jejuni WT (*P < 0.05; **P < 0.01).
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to compare inflammatory responses with macrophages 
or avian and murine origin (Figure 3). All three strains of 
C. jejuni elicited expression of IL-6 mRNA in huMDMs 
regardless of the bacteria being live or fixed, but no sig-
nificant differences between WT and capsule (Δcj1439) 
or MeOPN (Δcj1417) mutants were found. Unlike IL-6, 
IL-10 transcription in huMDM were not affected by nei-
ther Salmonella LPS nor the different strains of C. jejuni.
Reduced number of intracellular C. jejuni in chicken 
and human macrophages due to the lack of MeOPN 
modification
To investigate the effect of the capsule and MeOPN mod-
ification on C. jejuni uptake and net intracellular survival 
in both chicken and human macrophages, a phagocyto-
sis assay was performed (Figure 4). Bacterial recoveries, 
after gentamicin treatment to kill extracellular bacteria, 
were used to quantify initial phagocytosis (presented 
as 0 h) and net intracellular survival (3 h after removal 
of gentamicin). In both chBMMs and huMDMs, there 
was no statistically significant differences in the num-
ber of C. jejuni taken up (T0) between the wild-type 
strain and acapsular mutant in macrophages. However, 
the lack of MeOPN modification led to a significantly 
reduced uptake (P  <  0.03) of intracellular C. jejuni in 
chBMMs and huMDMs compared to the WT and aca-
psular mutant (Figure  4A). The percentage of bacteria 
surviving at 3 h post-incubation revealed no significant 
difference of net intracellular survival between WT and 
MeOPN mutants in chBMMs and huMDMs (Figure 4B). 
The acapsular mutant showed a slight but significant 
increase in the percentage of bacteria killed in huMDMs, 
but not chBMMs, 3 h post-incubation compared to WT 
of C. jejuni.
Figure 2 Wild-type and capsule or MeOPN deficient strains of C. jejuni induce similar cytokine responses in chBMMs. Live or fixed C. 
jejuni 11168H (WT), Δcj1417 (MeOPN) and Δcj1439 (capsule) mutants were incubated with chBMMs at MOI 50 for 3 and 6 h. Salmonella LPS (100 ng/
mL) was used as a positive control and mRNA levels of target genes were presented as folder changes compared to PBS in the medium (a negative 
control). Graphs show representative results of three independent experiments and error bars are standard deviation of three independent experi-
ments. Asterisks indicate a statistically significant difference of mRNA levels of inflammatory-related cytokines compared to PBS in the medium 
(*P < 0.01; **P < 0.001).
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Figure 3 Wild-type and capsule or MeOPN deficient strains C. jejuni induce similar cytokine responses in huMDMs. Live or fixed C. jejuni 
11168H (WT), Δcj1417 (MeOPN) and Δcj1439 (capsule) mutants were incubated with huMDMs at MOI 50 for 3 h. Salmonella LPS was used as a posi-
tive control, and mRNA levels of target gene was presented as folder changes compared to PBS in the medium (a negative control). Graphs show 
representative results of three individual donors (two individuals for fixed C. jejuni). Error bars are standard deviation of three (two) independent 
experiments. Asterisks indicate a statistically significant difference of mRNA levels for the indicated inflammation-related cytokines compared to PBS 
in the medium (*P < 0.01).
Figure 4 The lack of MeOPN modification affects the number of intracellular C. jejuni in macrophages. Chicken or human macrophages 
were incubated with C. jejuni 11168H (WT), Δcj1417 (MeOPN) and Δcj1439 (capsule) mutant at MOI 50 for 30 min. Intracellular bacteria were 
assessed by a gentamicin protection assay, and counted at 0 h after removal of gentamicin (T0, open bar) and after a further 3 h (T3, closed bar) 
of incubation. The average number of colonies at T0 and T3 are presented as  Log10 CFU/mL (A). The percentage of killed bacteria was calculated 
using the average number of colonies at T0 and T3 (B). Each bar represents mean of three independent experiments and error bars are the standard 
deviation of three independent experiments. Asterisks indicate a statistically significant difference of the number of survived bacteria (A) and the 
percentage of killed bacteria (B) in different treatment (P < 0.05).
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Discussion
There has been concerted effort to better understand 
the differences between the avian and human immune 
response to C. jejuni infection [9, 10, 14, 21]. Recently, 
important roles for the capsule and its MeOPN modifi-
cation have been demonstrated in cell adherence, inva-
sion, colonisation, serum resistance and host immune 
responses [26, 30, 31, 33]. In this study, we compared 
the cytokine responses of macrophages of different host 
origin known to differ in their symptoms upon infec-
tion with C. jejuni. The phagocytic and killing capacity 
of chicken and human macrophages to C. jejuni and cap-
sule or MeOPN deficient mutants were analysed to better 
understand these differential responses observed in vivo. 
Although macrophages are not the first cells to contact C. 
jejuni during the infection in mucosal environment, intes-
tinal and colonic macrophages are part of the first line 
defence mechanism since they are located strategically 
underneath the epithelial lining in close proximity to large 
numbers of luminal bacteria and antigenic stimuli. These 
gut macrophages regulate inflammatory responses to bac-
teria and antigens that cross the epithelium, protect the 
mucosa against harmful pathogen and scavenge dead cells 
and foreign debris by crosstalking with adjacent intestinal 
epithelial cells through TLR-dependent signalling path-
way [46, 47]. Additionally, a recent study reported cross-
talk between intestinal epithelial cells and macrophages 
mediated through TLR4, resulting in the production of 
IL-10 from human intestinal epithelial cells [48].
Using the current WT, capsule (Δcj1439) and MeOPN 
(Δcj1417) strains of C. jejuni, we were able to reproduce 
the enhanced expression of IL-6 and IL-10 mRNA levels 
in mBMDCs by capsule and MeOPN deficient strains 
of C. jejuni compared to the WT strain, as reported by 
Rose et  al. [33]. We also found that mBMMs incubated 
with the mutant strains expressed elevated levels of IL-6 
and IL-10 mRNA compared to the C. jejuni WT, suggest-
ing a potential role for capsule and MeOPN modification 
in bacterial evasion of mouse innate immune responses. 
In the context of zoonosis however, it is more relevant 
to consider the response of avian and human cells to C. 
jejuni infection and the role of bacterial factors in this 
process. For this purpose, the mRNA levels of IL-1β, IL-6 
and CXCLi1 (pro-inflammatory cytokine/chemokine) 
and IL-10 (anti-inflammatory cytokine) were measured 
to examine the immune response of chicken, based on 
Smith et  al. [21]. As markers of human responses, the 
expression of IL-6 and IL-10 mRNA was measured based 
on Rose et  al. [33]. All three strains of C. jejuni signifi-
cantly induced mRNA levels of inflammation-related sig-
nature genes in both chicken and human macrophages, 
indicating that C. jejuni is highly immunogenic to both 
avian and human primary macrophages. These results 
are very similar with early reports that C. jejuni is highly 
immunogenic to both human and mouse macrophage 
cell lines [14, 20]. However, neither capsule nor MeOPN 
deficient mutants altered the cytokine responses in 
chicken and human macrophages, when compared to 
WT, in contrast to the responses of mouse macrophages, 
indicating that neither of structures is vital for the induc-
tion of an immune response in human and avian cells.
All three strains of C. jejuni induced significant mRNA 
levels of IL-10 in chBMMs and mBMMs compared to 
PBS in the medium (as negative control). However, there 
was no significant increase in IL-10 transcripts in huM-
DMs observed by C. jejuni WT, capsule (Δcj1439) and 
MeOPN (Δcj1417) mutants. In fact, the expression lev-
els of IL-10 mRNA in huMDMs from all three donors 
was relatively high compared to chBMMs and mBMMs, 
although the high expression of IL-10 mRNA did not 
appear to affect the expression of IL-6 during the stimula-
tion with C. jejuni. Except for the different origin of mac-
rophages between bone marrow and monocytes, there 
is no obvious explanation for the different responses of 
IL-10 mRNA levels in huMDMs to C. jejuni compared to 
chBMMs and mBMMs.
It has been reported that the capsule (Δcj1439) mutant 
showed significantly decreased adherence and inva-
sion to the epithelial cells [30, 31], while the MeOPN 
(Δcj1417) mutant has shown increased invasion (but 
no defect in adherence) to epithelial cells compared to 
wild-type strains [30]. Additionally, the lack of MeOPN 
modification, as well as capsule, leads to the significantly 
decreased serum resistance, indicating a potentially pro-
tective role for MeOPN modification against the innate 
immune system [30]. Our phagocytosis study showed 
decreased C. jejuni uptake in the absence of MeOPN 
modification in chicken and human macrophages com-
pared to C. jejuni WT; however, the lack of MeOPN 
modification did not affect net intracellular survival in 
chicken and human macrophages. On the other hand, the 
capsule did not affect bacterial uptake or net intracellular 
survival at least at the time intervals sampled.
In summary, chicken and human macrophages showed 
similar responses to C. jejuni WT, capsule (Δcj1439) 
and MeOPN (Δcj1417), unlike mouse macrophages. The 
absence of MeOPN modification on the capsule of C. 
jejuni did not alter the cytokine responses, as well as net 
intracellular survival in chicken and human macrophages 
compared to C. jejuni 11168H, but it affected C. jejuni 
uptake by chicken and human macrophages. The study 
indicates that extrapolation of findings regarding the 
potential contribution of candidate virulence factors and 
host responses to pathogenesis may not always be repro-
duced across comparable cell types originating from 
other hosts.
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